Comparing Major and Mild Cognitive Impairment Risks in Older Type-2 Diabetic Patients: a Danish Register-Based Study on Dipeptidyl Peptidase-4 Inhibitors Vs. Glucagon-Like Peptide-1 Analogues

Vera Battini,Maria Antonietta Barbieri,Carla Carnovale,Edoardo Spina,Emilio Clementi,Maurizio Sessa

Journal of Neurology（2024）

引用 0|浏览22
暂无评分
摘要
The prevalence of major and mild cognitive impairment (CI) in type-2 diabetes older patients is 15–25
更多
查看译文
关键词
Glucagon-like peptide-1 analogues,Dipeptidyl peptidase-4 inhibitors,Major cognitive impairment,Mild cognitive impairment,Older individuals,Register-based study
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要